Frank Sievert
Inventor
Stats
- 3 US patents issued
- 6 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 3 US Patents Issued
- 6 US Applications Filed
- 25 Total Citation Count
- Jul 25, 2013 Most Recent Filing
- Jun 23, 1995 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| SCHWARZ PHARMA AG | 2
1 | 1995
1997 |
| TEVA PHARMACEUTICALS USA, INC. | 1
| 2012
|
| SDGI HOLDINGS, INC. | 1
| 1997
|
| RATIOPHARM GMBH | 1
1 | 2012
2013 |
Inventor Addresses
| Address | Duration |
|---|---|
| Allmendingen, DE | Aug 02, 12 - Sep 03, 15 |
| Burscheid, DE | Mar 18, 97 - Mar 16, 99 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61J: | CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE | 2 |
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 6 |
| B05D: | PROCESSES FOR APPLYING LIQUIDS OR OTHER FLUENT MATERIALS TO SURFACES, IN GENERAL | 1 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2015/0246,043 | 2015 | ORAL DOSAGE FORMS FOR MODIFIED RELEASE COMPRISING RUXOLITINIB | 0 |
| 2013/0344,149 | 2013 | Oral Dosage Forms for Modified Release Comprising Tasocitinib | 10 |
| 2012/0195,966 | 2012 | ORAL DOSAGE FORM FOR MODIFIED RELEASE COMPRISING A JAK3 INHIBITOR | 0 |
| 5882684 | 1999 | Lyophilized emulsion containing an active substance | 2 |
| 5681855 | 1997 | PGE.sub.1 emulsion composition kit | 1 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.